Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Sloping forehead, Anteverted nares, Gait ataxia, and Narrow mouth and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 4 | Short distal phalanx of finger, Lower limb hypertonia, Clinodactyly of the 4th finger |
Biomarker and diagnostic research for chromosome 2p12-p11.2 deletion syndrome has been reported in the published literature.
Phenotype severity distribution: 33 always present features.
No clinical trials have been registered for chromosome 2p12-p11.2 deletion syndrome.
200 publications have been identified in PubMed for chromosome 2p12-p11.2 deletion syndrome. Research spans Basic Science / Preclinical (28%), Review / Meta-Analysis (27%), and Case Report / Case Series (22%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 49 | 28% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC
Online Mendelian Inheritance in Man
Common questions about chromosome 2p12-p11.2 deletion syndrome
3 |
Gait ataxia, Aggressive behavior, Global developmental delay |
Head and neck | 2 | Thin upper lip vermilion, High palate |
Growth and development | 2 | Postnatal growth retardation, Intrauterine growth retardation |
Digestive system | 1 | Feeding difficulties |
Eyes | 1 | Ptosis |
Ears | 1 | Conductive hearing impairment |
Blood and immune system | 1 | Low platelet count (thrombocytopenia) |
Research summaries
46 |
27% |
Patient case studies | 38 | 22% |
Disease patterns and progression | 22 | 13% |
Testing and diagnosis research | 8 | 5% |
Clinical study results | 7 | 4% |
New treatment approaches | 3 | 2% |
Gąsiorowska J (2026). [PMID: 42023627](https://pubmed.ncbi.nlm.nih.gov/42023627/). *Pediatr Endocrinol Diabetes Metab*. [Review / Meta-Analysis]
Yang S (2026). [PMID: 41690495](https://pubmed.ncbi.nlm.nih.gov/41690495/). *Clin Chim Acta*. [Review / Meta-Analysis]
Minale EMP (2026). [PMID: 42003802](https://pubmed.ncbi.nlm.nih.gov/42003802/). *Mol Genet Genomic Med*. [Review / Meta-Analysis]
van der Laan L (2026). [PMID: 41028553](https://pubmed.ncbi.nlm.nih.gov/41028553/). *Eur J Hum Genet*. [Basic Science / Preclinical]
Costa SD (2026). [PMID: 40566944](https://pubmed.ncbi.nlm.nih.gov/40566944/). *J Child Neurol*. [Case Report / Case Series]
Butler MG (2026). [PMID: 41683698](https://pubmed.ncbi.nlm.nih.gov/41683698/). *Int J Mol Sci*. [Review / Meta-Analysis]
Kikas T (2026). [PMID: 41338233](https://pubmed.ncbi.nlm.nih.gov/41338233/). *Hum Reprod*. [Epidemiology / Natural History]
Ishida C (2026). [PMID: 32809547](https://pubmed.ncbi.nlm.nih.gov/32809547/). *Unknown Journal*. [Basic Science / Preclinical]
Firn K (2026). [PMID: 40465813](https://pubmed.ncbi.nlm.nih.gov/40465813/). *Unknown Journal*. [Epidemiology / Natural History]
Levy T (2025). [PMID: 40858310](https://pubmed.ncbi.nlm.nih.gov/40858310/). *Am J Intellect Dev Disabil*. [Epidemiology / Natural History]